Although no official announcement has been made, former Senate majority leader Tom Daschle is most likely slated to head the Obama administration’s efforts to enact health reform legislation as the new secretary of the Department of Health and Human Services.
Although no official announcement has been made, former Senate majority leader Tom Daschle is most likely slated to head the Obama administration’s efforts to enact health reform legislation as the new secretary of the Department of Health and Human Services. Daschle has been a close advisor to Obama, and his long experience on Capitol Hill makes him a prime choice to steer health legislation through Congress. Reform advocates consider the selection a sign that the Obama administration will seek to fulfill its promises to make health reform a top priority.
Daschle’s familiarity with health policy issues is evident in the book he co-authored earlier this year: Critical: What We Can Do about the Health-Care Crisis. But with less administrative experience than the governors who preceded him, Daschle will need capable deputies to oversee key HHS agencies, including the Food and Drug Administration, the National Institutes of Health, Medicare, and Medicaid.
The former Senator from South Dakota lost his seat in a hard-fought battle in 2004. He was criticized then as being too much of a Washington insider, and his nomination provoked similar comments from some parties. But most observers regard the appointment as a realistic assessment that consummate political skill is needed to reform the nation’s healthcare system.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.